Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma Journal Article


Authors: Politi, K.; Fan, P. D.; Shen, R.; Zakowski, M.; Varmus, H.
Article Title: Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma
Abstract: Seventy-five percent of lung adenocarcinomas with epidermal growth factor receptor (EGFR) mutations respond to treatment with the tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib; however, drug-resistant tumors eventually emerge. In 60% of cases, resistant tumors carry a secondary mutation in EGFR (T790M), amplification of MET, or both. Here, we describe the establishment of erlotinib resistance in lung tumors, which were induced by mutant EGFR, in transgenic mice after multiple cycles of drug treatment; we detect the T790M mutation in five out of 24 tumors or Met amplification in one out of 11 tumors in these mice. This preclinical mouse model, therefore, recapitulates the molecular changes responsible for resistance to TKIs in human tumors and holds promise for the discovery of additional mechanisms of drug resistance in lung cancer.
Keywords: signal transduction; genetics; mutation; erlotinib; adenocarcinoma; cell proliferation; mouse; animal; metabolism; animals; mice; gene amplification; lung neoplasms; epidermal growth factor receptor; receptor, epidermal growth factor; drug effect; drug resistance; pathology; drug resistance, neoplasm; transgenic mouse; mice, transgenic; disease model; lung tumor; transgene; disease models, animal; quinazolines; quinazoline derivative; transgenes; scatter factor receptor; proto-oncogene proteins c-met
Journal Title: Disease Models & Mechanisms
Volume: 3
Issue: 1
ISSN: 1754-8403
Publisher: Company of Biologists  
Date Published: 2010-01-01
Start Page: 111
End Page: 119
Language: English
PUBMED: 20007486
PROVIDER: scopus
PMCID: PMC2806903
DOI: 10.1242/dmm.003681
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 20 April 2011" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ronglai Shen
    205 Shen
  2. Maureen F Zakowski
    289 Zakowski
  3. Katerina A Politi
    23 Politi
  4. Pang-Dian Fan
    15 Fan
  5. Harold Varmus
    96 Varmus